Am J Physiol Cell Physiol AJP: Heart and Circulatory Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Cell Physiol 290: C672-C677, 2006. First published October 5, 2005; doi:10.1152/ajpcell.00331.2005
0363-6143/06 $8.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
290/3/C672    most recent
00331.2005v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Web of Science (2)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Potokar, M.
Right arrow Articles by Zorec, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Potokar, M.
Right arrow Articles by Zorec, R.

GROWTH, DIFFERENTIATION, AND APOPTOSIS

Subcellular localization of Apaf-1 in apoptotic rat pituitary cells

Maja Potokar,1,2 Marko Kreft,1,2 Helena H. Chowdhury,1,2 Nina Vardjan,2 and Robert Zorec1,2

1Laboratory of Neuroendocrinology-Molecular Cell Physiology, Institute of Pathophysiology, Medical Faculty, University of Ljubljana, Ljubljana; and 2Celica Biomedical Sciences Center, Ljubljana, Slovenia

Submitted 5 July 2005 ; accepted in final form 30 September 2005


    ABSTRACT
 TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
A key step in the intrinsic apoptotic pathway is the assembly of the apoptosome complex. The apoptosome components are well known; however, the physiology of the assembly of the apoptosome complex at the cellular level is still poorly defined. The aim of this work was to study the subcellular distribution of the apoptosome scaffold protein apoptotic protease-activating factor 1 (Apaf-1) before and after triggering apoptosis in single somatotrophs. Somatotrophs are the subject of extensive pituitary tissue remodeling in different physiological situations in which the quality and the number of pituitary cells are determined by cell proliferation and apoptosis. We show herein that 2 h after triggering apoptosis with rotenone, Apaf-1 redistributed to the proximity of mitochondria. In addition, the degree of colocalization between Apaf-1 and fluorescently labeled caspase-9 significantly increased during the same period. Furthermore, we show herein for the first time in single cells that the colocalization between Apaf-1 and cytochrome c increases only transiently, indicating a transient interaction between cytochrome c and Apaf-1 during the activation of apoptosis in these cells.

cytochrome c; caspase-9; apoptosis; apoptosome complex


THE ANTERIOR PITUITARY COMPRISES five unique cell types (somatotrophs, lactotrophs, thyrotrophs, gonadotrophs, and corticotrophs; Ref. 27). Somatotrophs, which constitute ~50% of anterior pituitary cells, synthesize and secrete growth hormone (27). The amount of hormone released is regulated by many cellular signaling mechanisms (34) and is also a function of the number of available cells (6). Cells proliferate in response to sustained stimulation with trophic hormones and hypothalamic peptides, and proliferation is reversed by a massive degeneration of surplus cells after the suppression of the specific stimulus (27, 32, 34). Apoptosis, or programmed cell death, involved in the remodeling of the pituitary is a tightly controlled process playing a general role in the regulation of cell quality and cell number in adult tissues and during embryonic development of all metazoan organisms (1, 12).

Generally, apoptosis can be triggered by various stimuli, such as direct ligation of receptors to the cell surface, leading to the activation of initiator caspases (caspase-8 or -10) or by intracellular stress, which causes damage to mitochondria (15, 24, 31). Stimuli that damage mitochondria trigger the activation of the initiator caspase-9 (14, 18), which is synthesized as an inactive proenzyme (7, 25). The main mode of caspase-9 activation takes place in the apoptosome complex, where the caspase-9 proenzyme binds to the apoptosome scaffold protein apoptotic protease-activating factor 1 (Apaf-1) in a cytochrome c- and dATP-dependent fashion (15). Upon cell damage, cytochrome c, a protein of the mitochondrial intermembrane space (17, 19), is released into the cytoplasm (17) and promotes apoptotic activity through binding to Apaf-1 (34). Binding of procaspase-9 to Apaf-1 leads to the cleavage of procaspase-9, converting it to an active caspase-9 (15). In pituitary somatotrophs, it appears that the caspase-9-proenzyme translocates to the proximity of mitochondria upon the activation of apoptosis (21), suggesting a mechanism of recruitment of apoptosome complex elements to the proximity of mitochondria, including Apaf-1.

To monitor the proteins of the apoptosome complex, we studied the subcellular localization of Apaf-1 compared with the localization of cytochrome c, caspase-9 tagged with enhanced green fluorescent protein (EGFP) (Casp9E), and mitochondria before and after triggering apoptosis in rat pituitary somatotrophs. The subcellular localization was studied by immunocytochemistry, confocal microscopy, subcellular fractionation, and quantitative image analysis. Our results show that 2-h treatment with rotenone induced the subcellular redistribution of Apaf-1 from the cytoplasm to the proximity of mitochondria. A similar phenomenon was shown previously for the redistribution of procaspase-9 (21). Interestingly, the degree of subcellular colocalization between Apaf-1 and Casp9E was maximal 2 h after rotenone treatment. Therefore, the mechanisms that regulate the redistribution of Apaf-1 and Casp9E to the proximity of mitochondria seem to operate in the same time scale.

Furthermore, the colocalization between cytochrome c and Apaf-1 increased transiently, which indicates that in the apoptosome complex, a stable, long-lasting interaction between cytochrome c and Apaf-1 is not required. Moreover, we demonstrate the time window for interactions between cytochrome c and Apaf-1 in a single cell.


    MATERIALS AND METHODS
 TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
Cell cultures. Primary cell cultures enriched for somatotrophs were prepared from the anterior lobe of pituitary glands of adult male rats (Wistar, 200–300 g) as described previously (3). Cells grown in a nutritive medium composed of 27% DMEM (Sigma), 54% nutrient mixture Ham's F-12 medium (Sigma), 9% {alpha}-MEM (Sigma), 25 mM D-glucose (Sigma), 25 mM HEPES (Sigma), 2 mM L-glutamine, and 3% UltroserG (Life Technologies) at 37°C in a 5% CO2 atmosphere were placed onto poly-L-lysine-coated coverslips before experiments. Cells from three different experiments were used for immunocytochemistry or DNA manipulation 24 h after cells were plated.

The animals were euthanized in accordance with the following ethical codes and directives: International Guiding Principles for Biomedical Research Involving Animals developed by the Council for International Organizations of Medical Sciences and the Directive on Conditions for Issue of License for Animal Experiments for Scientific Research Purposes (Official Gazette of the Republic of Slovenia 40/85 and 22/87).

DNA, immunocytochemistry, and subcellular fractionation. Cells were transiently transfected with a plasmid containing a cloned sequence of the fusion protein Casp9E (21). The DNA was introduced into cells using LipofectAMINE Plus reagent (Invitrogen) according to the manufacturer's instructions. For immunocytochemistry, the following primary antibodies were used: anti-cytochrome c and anti-Tim23 (BD Biosciences) and anti-Apaf-1 (Abcam) as used in previous studies (5, 9, 15, 35). First, cells were washed with PBS, fixed in 4% paraformaldehyde in PBS for 15 min, and then incubated in 0.1% Triton X-100 for 10 min at room temperature. Nonspecific staining was reduced by incubating cells in blocking buffer containing 3% BSA and 10% goat serum in PBS at 37°C for 1 h. The cells were stained with primary and secondary antibodies diluted in 3% BSA in PBS and incubated at 37°C. Subsequently, they were mounted using the Light Antifade kit (Molecular Probes). Double staining was performed in the same way as staining with a single antibody, except that the two primary antibodies (raised in different species) were added sequentially. Secondary antibodies conjugated to fluorescent dyes Alexa Fluor 546 (red; Molecular Probes) or Alexa Fluor 488 (green; Molecular Probes) were used. Subcellular fractionation was performed using the Cytosol/Mitochondria Fractionation kit (Oncogene). Briefly, after isolation, cells were collected by being centrifuged at 600 g for 5 min at 4°C, washed with ice-cold PBS, and centrifuged again at 600 g for 5 min at 4°C. The supernatant was removed, and cells were resuspended with 1x cytosol extraction buffer mix containing protease inhibitors. Cells were homogenized at 4°C with 30–50 passes using a pestle in a 1.5-ml microcentrifuge tube. The homogenate was centrifuged at 700 g for 10 min at 4°C. The supernatant was transferred to a fresh microcentrifuge tube and centrifuged at 10,000 g for 30 min at 4°C. At the end, the supernatant was collected as the cytosolic fraction and the pellet was resuspended in the mitochondrial extraction buffer mix. Primary antibodies used for Western blot analysis were anti-cytochrome c (BD Biosciences) and anti-Apaf-1 (Abcam; Stressgen) diluted according to the manufacturer's instructions. Western blot analysis was performed with the BM chemiluminescence Western blotting kit (mouse/rabbit) (Roche), in which the concentration of horseradish peroxidase-labeled secondary antibodies was 60 mU/ml.

Induction of apoptosis. Apoptosis was triggered with rotenone, an inhibitor of complex I in the mitochondrial respiratory chain (10, 16). Rotenone is widely used in studies of the activation of mitochondria-dependent caspase pathways (20, 21, 29, 30). Unless stated otherwise, cells were incubated with 300 µM rotenone for the following periods (in min): 1, 5, 10, 15, 30 and 120. Apoptotic cells were demonstrated by labeling with annexin V-Alexa Fluor 568 conjugate (Molecular Probes), which stains the plasma membrane of apoptotic cells. To detect possible necrotic cells, we used Sytox Green nucleic acid stain (Molecular Probes), which does not permeate intact plasma membrane. Cells were stained under the confocal microscope according to the manufacturer's instructions, and the fractions of apoptotic and necrotic cells, respectively, were determined by counting all cells on a glass coverslip onto which 50,000 cells had been seeded. The experiment was repeated in two culture preparations.

Confocal microscopy and image analysis. The fluorescent images were collected from equatorial planes of cells with optical thickness of 2 µm using an inverted Zeiss LSM 510 confocal microscope (x40 oil-immersion lens objective, numerical aperture 1.3). To obtain intensity profiles, lines were drawn through the middle of the cell images. EGFP and the conjugate Alexa Fluor 488 were excited using an argon laser (488 nm). Fluorescence was collected through the band-pass filter (505–530 nm). For excitation of the conjugate Alexa Fluor 546, the HeNe laser (543 nm) was used in combination with a long-pass filter with the cutoff set at <560 nm. The green and red signals were acquired sequentially.

Confocal images were analyzed using custom-made MatLab software as described previously (13, 21). Briefly, the images obtained were exported as eight-bit tagged image file format, or TIFF, files and analyzed using the MatLab software (13) by counting the number of green, red, and colocalized pixels in each image. The degree of colocalization was used to compare two fluorescently tagged proteins and expressed as the percentage of colocalized pixels in the cell among all pixels in the cell. Overlaid green and red signals, indicating colocalization between the two proteins, were indicated by yellow coloration in the images. Data were analyzed using a two-tailed Student's t-test for equal variance.


    RESULTS
 TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
Apaf-1 redistributes to mitochondria after triggering apoptosis with rotenone. First, we checked the distribution of Apaf-1 compared with the distribution of mitochondria before and after triggering apoptosis. Control cells and cells incubated with rotenone for 1, 5, 10, 15, and 30 min had a similar, relatively low degree of colocalization between the labeled proteins Apaf-1 and Tim23, a protein of the internal mitochondrial membrane (2) (Fig. 1C). However, after applying 2-h treatment with rotenone, we noticed a significant increase in the degree of colocalization between Apaf-1 and mitochondria (Fig. 1C). The change in the relative subcellular distribution of Apaf-1 to the proximity of mitochondria, shown in Fig. 1A, was similar to one found previously in the case of procaspase-9 (21). Furthermore, the line intensity profiles confirmed the distinct distribution of both labeled proteins in control cells (Fig. 1B). However, in apoptotic cells treated for 2 h with rotenone, a noticeable colocalization between the two signals was observed (Fig. 1B). The level of fluorescent signal colocalization in control cells was, on average, 23 ± 2% (n = 33), and in cells treated for 2 h with rotenone, it was 44 ± 3% (n = 34), a statistically significant difference (P < 0.001) (Fig. 1C).


Figure 1
View larger version (39K):
[in this window]
[in a new window]
 
Fig. 1. The apoptosome scaffold protein apoptotic protease-activating factor 1 (Apaf-1) redistributes to mitochondria after triggering apoptosis. A: mitochondria were labeled with antibody against internal mitochondrial protein Tim23 (anti-Tim23, green), and the cytoplasmic protein Apaf-1 was labeled with antibody against Apaf-1 (anti-Apaf-1, red). In control cells (Control), Apaf-1 and mitochondria were poorly colocalized (overlay) but rotenone induced the redistribution of Apaf-1 to mitochondria (+2 h rotenone, overlay). Cells were treated with 300 µM rotenone. Bars, 5 µm. B: profiles of fluorescence signals (expressed as arbitrary units, A.U.) from the control cell confirm different distribution of Apaf-1 and mitochondria (left), whereas profiles from the rotenone-treated cell confirm a similar distribution pattern between Apaf-1 and mitochondria (right). C: graph representing average degree of colocalized signals of fluorescently labeled Apaf-1 and Tim23. No significant difference was detected between the controls and rotenone-treated cells for 1, 5, 10, 15, and 30 min. However, a significant increase in the mean degree of colocalization between Apaf-1 and mitochondria (Tim23) was detected after 2-h incubation [increase from 23 ± 2% in control (n = 33) to 44 ± 3% in rotenone-treated cells for 2 h (n = 34); *P < 0.001]. The degrees of colocalization were 20% in the control cell (Control) shown in A, left, and 44% in rotenone-treated cell for 2 h shown in A, right (+2 h rotenone, overlay). Numbers above columns represent number of cells analyzed for each condition.

 
Degree of colocalization between Apaf-1 and cytochrome c transiently increases in apoptotic cells. We further tested the subcellular distribution of Apaf-1 and cytochrome c in control and in rotenone-treated cells. The results show that 15-min incubation with rotenone induced a significant increase in the degree of colocalization between cytochrome c and Apaf-1 (43 ± 3%, n = 15; P < 0.01) (Fig. 2, A and C). However, this event turned out to be transient. Cells treated with rotenone for 1, 5, 10, and 30 min and 2 h, respectively, showed a relatively low degree of colocalization between cytochrome c and Apaf-1, similarly to observations in control cells (Fig. 2C). In contrast to the increased colocalization of Apaf-1 and mitochondria or Casp9E, respectively (Figs. 1 and 4), 2-h treatment with rotenone did not cause increased colocalization between cytochrome c and Apaf-1 compared with control cells (Fig. 2A). This finding was further confirmed by performing fluorescence intensity line profiles (Fig. 2B). The transient increase in the degree of the colocalization between Apaf-1 and cytochrome c is consistent with an increased transient potential for the interaction between the two proteins. To further test the localization of Apaf-1 and cytochrome c, we used subcellular fractionations (Fig. 3). The results showed that in the absence of rotenone, Apaf-1 was found in the cytosol. A similar distribution was found after 15-min or 2-h incubation with rotenone (Fig. 3). However, no Apaf-1 was detected in the mitochondrial fractions when the amount of protein loaded onto the gel was the same (1 µg) as that in the cytosolic fractions (Fig. 3). To check whether any trace of Apaf-1 could be detected in the mitochondrial fraction after rotenone treatment, the amount of proteins loaded onto the gel was greatly increased (from 1 to 15 µg). In this case, a faint band of Apaf-1 in the mitochondrial fraction of cells treated for 15 min with rotenone was detected. After apoptosis was triggered, the amount of cytochrome c decreased in the mitochondrial fractions with a concomitant small increase of cytochrome c in the cytosolic fraction.


Figure 2
View larger version (48K):
[in this window]
[in a new window]
 
Fig. 2. The degree of colocalization between cytochrome c (Cyt c) and Apaf-1 was transiently increased after rotenone application. A: control (Control) and rotenone-treated cells for 15 min (+15 min rotenone) and 2 h (+2 h rotenone) immunolabeled with antibody against cytochrome c (anti-Cyt c, green) and antibody against Apaf-1 (anti-Apaf-1, red). Overlaid signals (Overlay) of both antibodies show that in the control cell, the two proteins were distributed in a granular fashion and were intertwined. The cells treated with rotenone for 15 min showed an increase in colocalization between cytochrome c and Apaf-1 (overlay, yellow). The same pattern observed in control cells was demonstrated in cells treated with rotenone for 2 h, in which the degree of the colocalization of the 2 proteins compared with control remained unchanged. Bars, 5 µm. B: profiles of fluorescence intensity emitted by antibodies against cytochrome c and Apaf-1 confirmed different distributions of both proteins in the control as well as in the rotenone-treated cell for 2 h, whereas in the cell incubated with rotenone for 15 min, the profiles of the 2 antibodies showed a similar distribution pattern. C: mean degree of overlaid signals between Apaf-1 and cytochrome c showed a transient increase in the degree of colocalization 15 min after rotenone application, whereas in cells treated with rotenone for different time intervals (1, 5, 10, 30, and 120 min), the degree of colocalization was similar to that of controls. The mean degree of colocalization in control cells was 27 ± 2% (31% in cell shown in A), whereas in cells treated for 15 min with rotenone, the mean colocalization was significantly higher at 43 ± 3%. *P < 0.01 (46% in cell shown in A). Mean colocalization 2 h after triggering apoptosis with rotenone was 31 ± 3%, which was similar to controls (29% in cell shown). Numbers above columns represent number of cells analyzed. Cells were treated with 300 µM rotenone.

 

Figure 4
View larger version (40K):
[in this window]
[in a new window]
 
Fig. 4. Apaf-1 becomes colocalized with caspase-9 tagged with EGFP (Casp9E) after triggering apoptosis with rotenone. A: somatotroph transfected with Casp9E (green) and stained with antibody against Apaf-1 (anti-Apaf-1, red). In control cells, Casp9E and Apaf-1 have distinct subcellular distributions (overlay). Rotenone-triggered apoptosis resulted in Casp9E and Apaf-1 redistribution to the same subcellular location (+2 h rotenone, overlay). Bar, 5 µm. B: intensity profiles of both fluorescent markers confirm distinct distributions of Casp9E and Apaf-1 in control conditions (left) and their redistribution to the same location after application of rotenone (right). C: average degree of colocalization between Casp9E and Apaf-1 in controls and in cells treated with rotenone for 1, 5, 10, 15, and 30 min was similar. However, after 2-h incubation with rotenone, a significant increase in the degree of colocalization was detected compared with controls [from 23 ± 2% (n = 25) in control cells to 47 ± 3% in rotenone-treated cells for 2 h (n = 30); *P < 0.01]. The degree of colocalized signals in the control cell shown in A, left, was 31% and it was 54% in the rotenone-treated cell shown in A, right. Cells were treated with 300 µM rotenone.

 

Figure 3
View larger version (29K):
[in this window]
[in a new window]
 
Fig. 3. Western blot analysis of Apaf-1 and cytochrome c in subcellular fractions. Left: Apaf-1 (~130 kDa) was detected mainly in the cytosolic fractions before and after triggering apoptosis (Cytosol). Apaf-1 was not detected in the mitochondrial fractions (Mitoch.) when the same amount of proteins used in the cytosolic fractions (1 µg) was loaded onto the gel. When proteins were loaded onto the gel in a 15 times larger amount (15 µg), a small increase in the amount of Apaf-1 was detected in the mitochondrial fractions of cells 15 min after triggering apoptosis (15 µg, 15 min). Right: cytochrome c (15 kDa) was increased in the cytosolic fraction after apoptosis was triggered with rotenone, along with a concomitant decrease in mitochondrial fractions. Cells were treated with 300 µM rotenone.

 
Apaf-1 and Casp9E are significantly colocalized after triggering apoptosis with rotenone. Apaf-1 and Casp9E showed a pattern similar to that of Apaf-1 and Tim23 regarding the degree of colocalization after triggering apoptosis (Figs. 1C and 4C). The time dependence of the degree of colocalization is shown in Fig. 4C. In cells treated with rotenone for 1, 5, 10, 15, and 30 min, Casp9E and Apaf-1 were poorly colocalized, similarly to observations in control cells (23 ± 2%; n = 25) (Fig. 4C). Rotenone treatment for 1–30 min did not significantly affect the distribution of Casp9E throughout the cell compared with controls (Fig. 4A). In contrast, in cells treated with rotenone for 2 h, a significant increase in colocalization between the signals from fluorescently labeled Apaf-1 and Casp9E was detected (47 ± 3%, n = 30; P < 0.01) (Fig. 4, A and C). The data regarding colocalization were further confirmed by comparing fluorescence intensity profiles (Fig. 4B). The increased colocalization between both proteins in apoptotic conditions was consistent with the model in which merging of both proteins was required for the activation of procaspase-9 (15).

Rotenone triggered apoptosis but not necrosis. We used a relatively high concentration of rotenone (300 µM) to trigger apoptosis. A 10-fold lower concentration of rotenone (30 µM) was also effective in inducing apoptosis, consistent with the findings of a previous study (21). To verify that rotenone induced apoptosis and not necrosis, we labeled cells with annexin V. Figure 5 shows that annexin V-positive cells were also present in control cells but that their percentage was rather low (0.5%). After rotenone application, the extent of annexin V-positive cells increased by at least one order of magnitude (Fig. 5). A few necrotic cells were present in control cultures, but their number was 50-fold less than the level of apoptotic cells. Although rotenone application elicited a small but not significant increase in necrotic cell count in the culture (from 0.01 to 0.04%), the fraction of apoptotic cells increased significantly by at least one order of magnitude as confirmed using Student's t-test (P < 0.01) (Fig. 5).


Figure 5
View larger version (69K):
[in this window]
[in a new window]
 
Fig. 5. Rotenone induced apoptosis but not necrosis. A: rotenone-triggered apoptotic cell labeled with annexin V-Alexa Fluor 568 conjugate (red). Bar, 5 µm. B: transmission image of the cell shown in A. C: number of apoptotic cells significantly increased after treatment with rotenone (+R, Ap.) compared with control cells (–R, Ap.). *P < 0.01. A few necrotic cells were found among control cells (–R, Ne.) and among rotenone-treated cells (+R, Ne.). The percentage of necrotic cells in conditions with and without rotenone was similar. Cells were treated with 300 µM rotenone for 2 h.

 

    DISCUSSION
 TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
The anterior pituitary exhibits a relatively large degree of plasticity because each type of cell proliferates in response to sustained stimulation, and proliferation is reversed by a massive degeneration of surplus cells (30). Therefore, these differentiated cells represent an interesting system in which to investigate apoptosis. The aim of this work was to study the subcellular distribution of the apoptosome complex major scaffolding component Apaf-1. Apaf-1 is a cytoplasmic protein (8, 35). A granular subcellular distribution of Apaf-1 was reported in HeLa cells, MCF-7 human breast carcinoma cells, and HepG2 hepatoblastoma cells before induction of apoptosis. Our experiments have confirmed the granular cytoplasmic distribution of Apaf-1 in nonapoptotic cells (Fig. 1). The exposure of cells to UV radiation or incubation with etoposide did not appear to alter the distribution of Apaf-1 in the cytoplasm (8). However, we found that in rotenone-treated rat pituitary cells, an increased fraction of anti-Apaf-1 signal was colocalized with the mitochondrial label 2 h after triggering apoptosis (Fig. 1A). After subcellular fractionation, a faint band of Apaf-1 was detected in the mitochondrial fraction only when the amount of protein loaded onto the gel was increased excessively (from 1 to 15 µg) (Fig. 3). Previously, it was reported that procaspase-9 translocated to the proximity of mitochondria and that it was detected simultaneously in mitochondrial fractions (21). The large subunit of caspase-9 was already found to be associated with the outer mitochondrial membrane (33), which is likely the reason why procaspase-9 was detected in the mitochondrial fraction (21). It is possible that Apaf-1 was detected in the mitochondrial fraction in our experiments for the same reason. Therefore, we assume that Apaf-1, similarly to Casp9E, translocates and associates with the outer membrane of the mitochondria.

On the basis of biochemical results, it was previously shown that the formation of the apoptosome complex is a multistep process (11, 15). During the early steps, cytochrome c released into the cytoplasm binds to Apaf-1 and induces oligomerization of Apaf-1 molecules (15, 23, 26, 35). First, we confirmed that after triggering apoptosis with rotenone, cytochrome c is released from the mitochondria (Fig. 3). Therefore, using immunocytochemistry, we expected to observe increased colocalization between cytochrome c and Apaf-1 in rotenone-treated cells. Interestingly, we have shown herein that the degree of colocalization between the two proteins increased only transiently (n = 15; P < 0.01) (Fig. 2C). Therefore, it appears that the potential for interaction between cytochrome c and Apaf-1 has a limited life span. On the other hand, a significant increase in the degree of colocalization between Apaf-1/Tim23 and Apaf-1/Casp9E was detected after 2-h incubation with rotenone and not at earlier time points investigated (Figs. 1C and 4C). These data are in agreement with observations obtained from cell lysates (22, 28). In cell lysates, the interacting proteins may bind less tightly once the apoptosome holoenzyme complex is formed and may be lost during purification (28). Therefore, until the present report, whether the lack of detection of cytochrome c in fractions, together with Apaf-1 and caspase-9, is due to inadequate detection techniques remained unexplained. We have shown for the first time the transient colocalization between cytochrome c and Apaf-1 in single cells, which supports the hypothesis that cytochrome c may be needed only for Apaf-1 oligomerization and that once the Apaf-1 oligomer is formed, cytochrome c unbinds from Apaf-1 (22). On the basis of the nonsynchronous rise in the degree of colocalization between Apaf-1/cytochrome c and Apaf-1/Casp9E, we assume that there is a significant delay between the binding of cytochrome c and caspase-9 to Apaf-1. Details of this delay need to be investigated in further studies. Moreover, we have shown for the first time the time window within which the interactions between cytochrome c and Apaf-1 occur.

The colocalization of Casp9E and Apaf-1 in apoptotic cells (Fig. 4) is consistent with the Apaf-1-facilitating function of caspase-9 activation by promoting the clustering of caspase-9 molecules (4). We cannot exclude nuclear localization of Casp9E in rat somatotrophs completely (21). However, 2-h treatment with rotenone induced a significant increase in the degree of colocalization between Casp9E and Apaf-1 (Fig. 4). Both proteins translocated to the proximity of mitochondria (Figs. 1 and 4) (21), which implies that the potential for both proteins to interact is greatly augmented under these conditions. The mechanisms that trigger the redistribution of both proteins seem to operate within the same time frame but remain to be determined.


    GRANTS
 TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
This work was supported by Grants P3 521 0381 and P3 0310 0381 from the Ministry of Education, Sciences, and Sports of the Republic of Slovenia; EC Contracts DECG QLG3-CT-2001-02004 and GROWBETA QLG1-CT-2001-02233; and National Institutes of Health Grant R01 NS-36665-05.


    ACKNOWLEDGMENTS
 
The involvement of Dr. I. Milisav-Ribaric during an early stage of this work is acknowledged.


    FOOTNOTES
 

Address for reprint requests and other correspondence: R. Zorec, Institute of Pathophysiology, Medical Faculty, Univ. of Ljubljana, Zaloska 4, SI-1000 Ljubljana, Slovenia (e-mail: Robert.Zorec{at}mf.uni-lj.si)

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.


    REFERENCES
 TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
1. Ashkenazi A and Dixit VM. Death receptors: signaling and modulation. Science 281: 1305–1308, 1998.[Abstract/Free Full Text]

2. Bauer MF, Hofmann S, Neupert W, and Brunner M. Protein translocation into mitochondria: the role of TIM complexes. Trends Cell Biol 10: 25–31, 2000.[CrossRef][Web of Science][Medline]

3. Ben-Tabou S, Keller E, and Nussinovitch I. Mechanosensitivity of voltage-gated calcium currents in rat anterior pituitary cells. J Physiol 476: 29–39, 1994.[Abstract/Free Full Text]

4. Cain K, Brown DG, Langlais C, and Cohen GM. Caspase activation involves the formation of the aposome, a large (approximately 700 kDa) caspase-activating complex. J Biol Chem 274: 22686–22692, 1999.[Abstract/Free Full Text]

5. Cecconi F, Alvarez-Bolado G, Meyer BI, Roth KA, and Gruss P. Apaf-1 (CED-4 homolog) regulates programmed cell death in mammalian development. Cell 94: 727–737, 1998.[CrossRef][Web of Science][Medline]

6. Chowdhury VS and Yoshimura Y. Cell proliferation and apoptosis in the anterior pituitary of chicken during inhibition and resumption of laying. Gen Comp Endocrinol 125: 132–141, 2002.[CrossRef][Web of Science][Medline]

7. Duan H, Orth K, Chinnaiyan AM, Poirier GG, Froelich CJ, He WW, and Dixit VM. ICE-LAP6, a novel member of the ICE/Ced-3 gene family, is activated by the cytotoxic T cell protease granzyme B. J Biol Chem 271: 16720–16724, 1996.[Abstract/Free Full Text]

8. Hausmann G, O'Reilly LA, van Driel R, Beaumont JG, Strasser A, Adams JM, and Huang DCS. Pro-apoptotic apoptosis protease-activating factor 1 (Apaf-1) has a cytoplasmic localization distinct from Bcl-2 or Bcl-XL. J Cell Biol 149: 623–634, 2000.[Abstract/Free Full Text]

9. Hu Y, Benedict MA, Wu D, Inohara N, and Núñez G. Bcl-XL interacts with Apaf-1 and inhibits Apaf-1 dependent caspase-9 activation. Proc Natl Acad Sci USA 95: 4386–4391, 1998.[Abstract/Free Full Text]

10. Isenberg JS and Klaunig JE. Role of the mitochondrial membrane permeability transition (MPT) in rotenone-induced apoptosis in liver cells. Toxicol Sci 53: 340–351, 2000.[Abstract/Free Full Text]

11. Jiang X and Wang X. Cytochrome c promotes caspase-9 activation by inducing nucleotide binding to Apaf-1. J Biol Chem 275: 31199–31203, 2000.[Abstract/Free Full Text]

12. Kerr JFR, Wyllie H, and Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26: 239–257, 1972.[Web of Science][Medline]

13. Kreft M, Milisav I, Potokar M, and Zorec R. Automated high through-put colocalization analysis of multichannel confocal images. Comput Methods Programs Biomed 74: 63–67, 2004.[CrossRef][Web of Science][Medline]

14. Li H, Zhu H, Xu C, and Yuan J. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 94: 491–501, 1998.[CrossRef][Web of Science][Medline]

15. Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, Alnemri ES, and Wang X. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91: 479–489, 1997.[CrossRef][Web of Science][Medline]

16. Lindahl PE and Oberg KE. The effect of rotenone on respiration and its point of attack. Exp Cell Res 23: 228–237, 1961.[CrossRef][Web of Science][Medline]

17. Liu X, Kim CN, Yang J, Jemmerson R, and Wang X. Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell 86: 147–157, 1996.[CrossRef][Web of Science][Medline]

18. Luo X, Budihardjo I, Zou H, Slaughter C, and Wang X. Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 94: 481–490, 1998.[CrossRef][Web of Science][Medline]

19. Mayer A, Neupert W, and Lill R. Translocation of apocytochrome c across the outer membrane of mitochondria. J Biol Chem 270: 12390–12397, 1995.[Abstract/Free Full Text]

20. Pei W, Liou AK, and Chen J. Two caspase-mediated apoptotic pathways induced by rotenone toxicity in cortical neuronal cells. FASEB J 17: 520–522, 2003.[Abstract/Free Full Text]

21. Potokar M, Milisav I, Kreft M, Stenovec M, and Zorec R. Apoptosis triggered redistribution of caspase-9 from cytoplasm to mitochondria. FEBS Lett 544: 153–159, 2003.[CrossRef][Web of Science][Medline]

22. Rodriguez J and Lazebnik Y. Caspase-9 and APAF-1 form an active holoenzyme. Genes Dev 13: 3179–3184, 1999.[Abstract/Free Full Text]

23. Saleh A, Srinivasula SM, Acharya S, Fishel R, and Alnemri ES. Cytochrome c and dATP-mediated oligomerization of Apaf-1 is a prerequisite for procaspase-9 activation. J Biol Chem 274: 17941–17945, 1999.[Abstract/Free Full Text]

24. Salvesen GS and Dixit VM. Caspases: intracellular signaling by proteolysis. Cell 91: 443–446, 1997.[CrossRef][Web of Science][Medline]

25. Srinivasula SM, Fernandes-Alnemri T, Zangrilli J, Robertson N, Armstrong RC, Wang L, Trapani JA, Tomaselli KJ, Litwack G, and Alnemri ES. The Ced-3/interleukin 1beta converting enzyme-like homolog Mch6 and the lamin-cleaving enzyme Mch2{alpha} are substrates for the apoptotic mediator CPP32. J Biol Chem 271: 27099–27106, 1996.[Abstract/Free Full Text]

26. Srinivasula SM, Ahmad M, Fernandes-Alnemri T, and Alnemri ES. Autoactivation of procaspase-9 by Apaf-1-mediated oligomerization. Mol Cell 1: 949–957, 1998.[CrossRef][Web of Science][Medline]

27. Torres AI, Pasolli HA, Maldonado CA, and Aoki A. Changes in thyrotroph and somatotroph cell populations induced by stimulation and inhibition of their secretory activity. Histochem J 27: 370–379, 1995.[Web of Science][Medline]

28. Twiddy D, Brown DG, Adrain C, Jukes R, Martin SJ, Cohen GM, MacFarlane M, and Cain K. Pro-apoptotic proteins released from the mitochondria regulate the protein composition and caspase-processing activity of the native Apaf-1/caspase-9 apoptosome complex. J Biol Chem 279: 19665–19682, 2004.[Abstract/Free Full Text]

29. Wang XJ and Xu JX. Possible involvement of Ca2+ signaling in rotenone-induced apoptosis in human neuroblastoma SH-SY5Y cells. Neurosci Lett 376: 127–132, 2005.[CrossRef][Web of Science][Medline]

30. Watabe M and Nakaki T. Rotenone induces apoptosis via activation of Bad in human dopaminergic SH-SY5Y cells. J Pharmacol Exp Ther 311: 948–953, 2004.[Abstract/Free Full Text]

31. Wei MC, Zong WX, Cheng EHY, Lindsten T, Panoutsakopoulou V, Ross AJ, Roth KA, MacGregor GR, Thompson CB, and Korsmeyer SJ. Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science 292: 727–730, 2001.[Abstract/Free Full Text]

32. Yu R and Melmed S. Oncogene activation in pituitary tumors. Brain Pathol 11: 328–341, 2001.[Web of Science][Medline]

33. Yuan H, Mutomba M, Prinz I, and Gottlieb RA. Differential processing of cytosolic and mitochondrial caspases. Mitochondrion 1: 61–69, 2001.[CrossRef][Web of Science][Medline]

34. Zorec R. Calcium signaling and secretion in pituitary cells. Trends Endocrinol Metab 7: 384–388, 1996.[CrossRef][Medline]

35. Zou H, Henzel WJ, Liu X, Lutschg A, and Wang X. Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell 90: 405–413, 1997.[CrossRef][Web of Science][Medline]

36. Zou H, Li Y, Liu X, and Wang X. An APAF-1 cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9. J Biol Chem 274: 11549–11556, 1999.[Abstract/Free Full Text]





This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
290/3/C672    most recent
00331.2005v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Web of Science (2)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Potokar, M.
Right arrow Articles by Zorec, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Potokar, M.
Right arrow Articles by Zorec, R.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2006 by the American Physiological Society.